Eric Ojerholm, M.D.
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
Philadelphia, PA 19104
BSE (Biomedical Engineering)
Duke University, 2008.
MD (Doctor of Medicine)
University of Pennsylvania, 2012.
Description of Clinical ExpertiseDr. Ojerholm is an Assistant Professor at the University of Pennsylvania and a staff physician at the Philadelphia VA Medical Center. He practices general radiation oncology, with a particular focus on cancers of the head/neck, lung, and prostate.
Dr. Ojerholm graduated as valedictorian from Duke University's School of Engineering (2004-2008). He earned a medical degree with Alpha Omega Alpha honors at the University of Pennsylvania (2008-2012) and then completed an internship in internal medicine (2012-2013) and a residency in radiation oncology (2013-2017) at the University of Pennsylvania. Dr. Ojerholm is board-certified in radiation oncology (2018). He was named the "Educator of the Year" by the University of Pennsylvania radiation oncology trainees (2019) and “Mentor of Excellence” by the American College of Radiation Oncology (2020).
Selected PublicationsSwisher-McClure S, Lukens JN, Aggarwal C, Ahn P, Basu D, Bauml JM, Brody R, Chalian A, Cohen RB, Fotouhi-Ghiam A, Geiger G, Gershowitz J, Livolsi V, Mitra N, Montone K, Newman J, Ojerholm E, O'Malley B Jr, Rajasekaran K, Tan E, Weinstein G, Lin A: A Phase II Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed Following Transoral Robotic Surgery for Human Papilloma Virus Related Squamous Cell Carcinoma of the Oropharynx. International Journal of Radiation Oncology, Biology, Physics 2019 Notes: in press.
Ojerholm Eric, Bekelman Justin E: Finding value for protons: the case of prostate cancer? Seminars in Radiation Oncology 28(2): 131-137, April 2018.
Ojerholm Eric, Hill-Kayser Christine E: Reply to Comment on: Insurance coverage decisions for pediatric proton therapy. Pediatric Blood & Cancer 65(1): e26827, January 2018.
Ojerholm Eric, Hill-Kayser Christine E: Insurance coverage decisions for pediatric proton therapy. Pediatric Blood & Cancer 65(1): e26729, January 2018.
Ojerholm Eric, Freedman Gary M, Bekelman Justin E: The Dollars and Sense of Hypofractionated Breast Radiation. Journal of the National Cancer Institute 109(11), November 2017.
McMillan Matthew T, Ojerholm Eric, Verma Vivek, Higgins Kristin A, Singhal Sunil, Predina Jarrod D, Berman Abigail T, Grover Surbhi, Robinson Cliff G, Simone Charles B: Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics 98(5): 1142-1152, Aug 2017.
Ojerholm Eric, Van Arsdalen Keith N, Roses Robert E, Tripp Patrick: Initiative to reduce bone scans for low-risk prostate cancer patients: A quasi-experimental before-and-after study in a Veterans Affairs hospital. Advances in Radiation Oncology 2(3): 416-419, July-September 2017.
Ojerholm Eric, Smith Andrew, Hwang Wei-Ting, Christodouleas John P: Reply to Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710. Cancer Jun 2017.
Ojerholm Eric, Lukens J Nicholas, Ahn Peter H, Geiger Geoffrey, Swisher-McClure Samuel, Newman Jason, Chalian Ara, Weinstein Gregory, O'Malley Bert W, Cohen Roger, Lin Alexander: Benefits of omitting primary site radiation therapy after transoral robotic surgery: Only time will tell. Practical Radiation Oncology 7(3): e157-e158, May - Jun 2017.
Ojerholm Eric, Smith Andrew, Hwang Wei-Ting, Baumann Brian C, Tucker Kai N, Lerner Seth P, Mamtani Ronac, Boursi Ben, Christodouleas John P: Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710. Cancer 123(5): 794-801, Mar 2017.
© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team.